Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARA | Q07869 | 3/20 | 0.46 |
| ▸ | BRD4 | O60885 | 1/20 | 0.43 |
| ▸ | BAZ2B | Q9UIF8 | 1/20 | 0.43 |
| ▸ | BAZ2A | Q9UIF9 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | MEN1 | O00255 | 4/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | DRD3 | P35462 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6812056 | 0.84 | KMT2A (0.51) | PPARAMAPTSMN1; SMN2L3MBTL1ALDH1A1 | |
| SCHEMBL27986848 | 0.82 | PPARA (0.44) | PPARABRD4BAZ2BBAZ2AMAPT | |
| SCHEMBL2274464 | 0.82 | CYP3A4 (0.44) | PPARABRD4BAZ2BBAZ2AMAPT | |
| SCHEMBL17826360 | 0.82 | PPARA (0.44) | PPARABRD4BAZ2BBAZ2AMAPT | |
| SCHEMBL11382828 | 0.82 | MAPT (0.50) | PPARABRD4BAZ2BBAZ2AMAPT | |
| SCHEMBL7840608 | 0.81 | KMT2A (0.37) | MAPTALDH1A1MEN1KMT2AKDM4E | |
| SCHEMBL5253980 | 0.79 | KMT2A (0.36) | PPARAMAPTALDH1A1MEN1KMT2A | |
| SCHEMBL11956604 | 0.79 | GSK3B (0.54) | MAPTALDH1A1MEN1KMT2ANPC1 | |
| SCHEMBL9274961 | 0.79 | KMT2A (0.40) | MAPTSMN1; SMN2ALDH1A1MEN1KMT2A | |
| SCHEMBL28757019 | 0.79 | CYP3A4 (0.48) | PPARABRD4BAZ2BBAZ2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230233714-A1 | NOVEL GADOLINIUM-BASED COMPOUND, METHOD FOR PRODUCING SAME, AND MRI CONTRAST AGENT CONTAINING SAME | KYUNGPOOK NATIONAL UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2023-07-27 | — | — | US | disclosed |
| US-11649203-B2 | Polymeric biomaterials derived from phenolic monomers and their medical uses | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2023-05-16 | — | — | US | disclosed |
| US-20200369597-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2020-11-26 | — | — | US | disclosed |
| US-10030009-B2 | Flavonoid derivative compounds and method for preparing same by depolymerization of condensed tannins | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) | 2018-07-24 | — | — | US | disclosed |
| US-20170260170-A1 | FLAVONOID DERIVATIVE COMPOUNDS AND METHOD FOR PREPARING SAME BY DEPOLYMERIZATION OF CONDENSED TANNINS | INSTITUT NATIONAL D'ETUDES SUPERIEURES AGRONOMIQUES DE MONTPELLIER (MONTPELLIER SUP AGRO) (FR) | 2017-09-14 | — | — | US | disclosed |
| US-5103022-A | Reacting dl-2-methyl-1-(4-trifluoromethylphenyl)-3-pyrrolidino -1-propanone with l-acetylphenylglycine to form corresponding diastereomeric salt, deposition, isolation of l-2-methyl-1-(4-trifluoromethylphenyl)-3-pyrrolidino-1-propanone | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1992-04-07 | — | — | US | disclosed |
| US-5057535-A | Muscle relaxants | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1991-10-15 | — | — | US | disclosed |
| EP-0200942-A2 | New derivatives of an aminoketone | NIPPON KAYAKU KABUSHIKI KAISHA (JP) | 1986-11-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10030009-B2 | Flavonoid derivative compounds and method for preparing same by depolymerization of condensed tannins | C9, MRPS27, RPS7 | PPARA 3803/4885BRD4 2331/4885BAZ2B 4272/4885 |
| US-20170260170-A1 | FLAVONOID DERIVATIVE COMPOUNDS AND METHOD FOR PREPARING SAME BY DEPOLYMERIZATION OF CONDENSED TANNINS | C9, MRPS27, RPS7 | PPARA 3803/4885BRD4 2331/4885BAZ2B 4272/4885 |
| US-20200369597-A1 | POLYMERIC BIOMATERIALS DERIVED FROM PHENOLIC MONOMERS AND THEIR MEDICAL USES | TH, TYR, TYRO3 | PPARA 1914/4885BRD4 1913/4885BAZ2B 4520/4885 |
| US-20230233714-A1 | NOVEL GADOLINIUM-BASED COMPOUND, METHOD FOR PRODUCING SAME, AND MRI CONTRAST AGENT CONTAINING SAME | GLRX3, GMNN, GRM2 | PPARA 741/4885BRD4 1175/4885BAZ2B 899/4885 |
| US-11649203-B2 | Polymeric biomaterials derived from phenolic monomers and their medical uses | TH, TYR, TYRO3 | PPARA 1914/4885BRD4 1913/4885BAZ2B 4520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.